GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Passive Air Capture Method Uses Evaporation to Crystallize Carbonates for CO₂ Removal

by GOAI
Share To

Researchers have introduced a new method for carbon dioxide removal from the atmosphere using passive air capture through evaporative carbonate crystallization. This approach, which falls under the category of direct air capture (DAC) technologies, offers a potential pathway to address CO₂ emissions by extracting the gas directly from ambient air. The technique focuses on utilizing natural evaporation processes to facilitate the crystallization of carbonate minerals, effectively capturing and storing atmospheric carbon dioxide.

The study highlights how this passive system operates without requiring significant energy input, relying instead on environmental conditions to drive the process. By leveraging evaporation, the method promotes the formation of solid carbonate crystals that permanently sequester CO₂. Researchers suggest that this approach could complement existing carbon removal strategies by providing an energy-efficient alternative for addressing legacy emissions and mitigating climate change impacts. Further investigation into scalability and implementation is ongoing as scientists explore its potential role in global carbon management efforts.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top